This website is for informational and educational purposes only. We do not sell Asthalin inhalers, tablets, respules, syrup or any other medicinal product. This information does not replace advice from your doctor or pharmacist.![]()
Asthalin Summary
Key facts
| Active ingredient | Salbutamol (called albuterol in the US) |
|---|---|
| Drug class | Short-acting beta-2 agonist (SABA) bronchodilator |
| Used for | Relief and prevention of asthma symptoms, exercise-induced bronchospasm, COPD |
| Starts working | Within 5 minutes (inhaled); about 30 minutes (tablets and syrup) |
| Lasts | About 4 to 6 hours (inhaled) |
| Forms | Inhaler (100 mcg/puff), Rotacaps (200 mcg), respules (2.5 mg/2.5 ml), syrup (2 mg/5 ml), tablets (2 mg, 4 mg) |
| Manufacturer | Cipla Limited, Mumbai, India |
| Status | Prescription medicine in most countries |
Background
Salbutamol (known as albuterol in the United States) was developed in 1966 by a British research team led by Sir David Jack at Allen & Hanburys. It was made by modifying the chemical structure of adrenaline to improve receptor selectivity, as a safer alternative to older, non-selective asthma treatments such as isoprenaline, which carried serious cardiovascular risks. Launched in 1969 (originally under the Ventolin brand), it was the first selective beta-2 adrenergic receptor agonist. This selectivity lets it relax bronchial smooth muscle and quickly relieve asthma attacks with fewer effects on the heart. More than 50 years later, salbutamol is on the World Health Organization's List of Essential Medicines and remains the most widely used "rescue" bronchodilator for asthma and COPD. Cipla sells it under the brand name Asthalin.
Medical uses
Asthalin is a "reliever" or "rescue" medicine rather than a preventer. It is used for:
- Relief of acute bronchospasm in asthma attacks, including wheezing, shortness of breath, chest tightness and coughing.
- Prevention of exercise-induced or allergen-induced bronchospasm, when taken 10–15 minutes before exposure to the trigger.
- Symptom relief in chronic obstructive pulmonary disease (COPD).
- The reversible component of airways obstruction, alongside inhaled corticosteroids in people with persistent asthma. In asthma, a reliever should not be the only or main treatment.
Salbutamol acts selectively on beta-2 adrenergic receptors in bronchial smooth muscle, relaxing the airway walls and widening the bronchial passages so air flows in and out of the lungs more easily. At normal doses it has little effect on beta-1 receptors in the heart, although heart-related side effects can still occur.
Dosage
Doses depend on age, formulation and the condition being treated, and should be set by a doctor. The table below shows the doses for the Asthalin 100 microgram inhaler from its official product information. Follow your doctor's instructions and the leaflet in your pack if they differ.
| Purpose | Adults and children 12+ | Children 4–11 years |
|---|---|---|
| Relief of symptoms | 1 puff (100 mcg), increased to 2 puffs if needed | 1 puff, increased to 2 puffs if needed |
| Before exercise or a known trigger | 2 puffs, 10–15 minutes before | 1 puff before, increased to 2 if needed |
| Regular (chronic) use | Up to 2 puffs, four times a day | Up to 2 puffs, four times a day |
| Maximum | 8 puffs in 24 hours; repeat doses usually no more often than every 4 hours | |
For babies and children under 4, and for the tablets, syrup, Rotacaps and respules, the dose is set by the prescriber based on age, weight and severity. Needing your reliever more often than usual, or more than twice a week, is a sign that your asthma is not well controlled, so see your doctor for a review.
Contraindications and precautions
Asthalin must not be used by anyone allergic (hypersensitive) to salbutamol or any of its ingredients. Non-intravenous salbutamol, including Asthalin, must not be used to stop uncomplicated premature labour or threatened miscarriage.
Use it with caution, and tell your doctor, if you have:
- an overactive thyroid (thyrotoxicosis)
- coronary heart disease, hypertrophic obstructive cardiomyopathy or a fast or irregular heart rhythm (tachyarrhythmia)
- high blood pressure
- diabetes
- low blood potassium, or if you take heart medicines called cardiac glycosides (such as digoxin)
Side effects
Asthalin is usually well tolerated at recommended doses, and most side effects are mild and short-lived.
- Common: fine tremor (especially of the hands), headache, dizziness, a fast heartbeat (tachycardia), and feeling tense or nervous.
- Less common: palpitations, mouth or throat irritation, muscle cramps and muscle pain.
- Rare: low blood potassium (hypokalaemia, especially with corticosteroids, diuretics or xanthines), widening of blood vessels, sleep problems, hallucinations (mainly in children), nausea, vomiting and dry mouth.
- Very rare but serious: allergic reactions such as angioedema, hives and low blood pressure; paradoxical bronchospasm (wheezing that suddenly gets worse straight after use, which means you must stop the medicine and get help); and heart rhythm problems such as atrial fibrillation.
An overdose can cause stronger versions of these effects, including low potassium, high blood sugar, agitation and, in severe cases, lactic acidosis. Get medical help straight away if you think you have taken too much.
Drug interactions
- Non-selective beta-blockers such as propranolol can block salbutamol's effect and should not usually be taken with it.
- Monoamine oxidase inhibitors, tricyclic antidepressants and digoxin may increase the risk of heart-related side effects.
- Xanthines (such as theophylline), corticosteroids, diuretics and long-term laxatives can add to salbutamol's potassium-lowering effect.
- Halogenated anaesthetics: salbutamol is usually stopped at least 6 hours before planned anaesthesia with these, where possible.
Pregnancy and breastfeeding
Salbutamol has been widely used in pregnancy for decades, and the NHS advises that salbutamol inhalers can be used during pregnancy and while breastfeeding, because poorly controlled asthma is a greater risk to mother and baby. Formal studies in pregnant women are limited, so the product information advises using it only when the expected benefit to the mother outweighs any possible risk to the baby. Salbutamol probably passes into breast milk in very small amounts. Talk to your doctor or midwife before starting or changing any asthma medicine.
Pharmacology
Salbutamol, the active ingredient in Asthalin, is a sympathomimetic amine that selectively stimulates beta-2 adrenergic receptors, found mainly in bronchial smooth muscle. This activates the enzyme adenylate cyclase, raising levels of cyclic AMP inside the cells, which relaxes the muscle and widens the airways.
After inhalation, about 10–20% of the dose reaches the lower airways; most of the rest is deposited in the mouth and throat and swallowed, then broken down by the liver (first-pass metabolism). Salbutamol is about 10% bound to plasma proteins and is cleared mainly by the kidneys, both unchanged and as an inactive phenolic sulfate metabolite. After intravenous use its elimination half-life is about 4 to 6 hours.
Manufacturer and market presence
Asthalin is made by Cipla Limited, one of the world's largest generic medicine manufacturers, headquartered in Mumbai, India. Cipla sells salbutamol under the Asthalin brand mainly in India and other markets in Asia, Africa and the Middle East. In the United Kingdom, Cipla EU Ltd holds the licence for the Asthalin 100 micrograms Inhaler. In other countries, salbutamol (albuterol) products are sold under different brand names, such as Ventolin (GSK) and ProAir or Proventil in the United States.




